U.S. markets closed

WuXi AppTec Co., Ltd. (603259.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
135.58-2.90 (-2.09%)
At close: 3:00PM CST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close138.48
Open135.32
Bid135.57 x 0
Ask135.58 x 0
Day's Range129.60 - 137.52
52 Week Range61.00 - 188.28
Volume25,216,003
Avg. Volume16,566,769
Market Cap329.827B
Beta (5Y Monthly)0.86
PE Ratio (TTM)106.76
EPS (TTM)1.27
Earnings DateOct 29, 2020
Forward Dividend & Yield0.24 (0.18%)
Ex-Dividend DateJun 04, 2020
1y Target Est102.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
      PR Newswire

      WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

      WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide.

    • Motley Fool

      These Office Properties Continue To Be Hot Commodities

      Because of that and the fact that cash is flowing into this sector due to the pandemic, life sciences campuses are hot commodities these days among real estate investors. A real estate fund managed by Brookfield is selling a best-in-class, 2.3 million-square-foot portfolio of lab office buildings to a fund managed by Blackstone for $3.45 billion. It enabled Brookfield to realize some of the value of its investment in Forest City Realty Trust.

    • WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award
      PR Newswire

      WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award

      WuXi AppTec, a leading global provider of R&D and manufacturing enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has received the 2020 Global Customer Value Leadership Award from Frost & Sullivan, a global business research and consulting firm. This marks the fourth consecutive year WuXi AppTec has been recognized by Frost & Sullivan for its leadership and innovative services.